LIST OF CONTENTS

1 EXECUTIVE SUMMARY 19

2 MARKET INTRODUCTION 21

2.1 DEFINITION 21

2.2 SCOPE OF THE STUDY 21

2.3 RESEARCH OBJECTIVE 21

2.4 MARKET STRUCTURE 22

2.5 ASSUMPTIONS & LIMITATIONS 22

3 RESEARCH METHODOLOGY 23

3.1 DATA MINING 23

3.2 SECONDARY RESEARCH 24

3.3 PRIMARY RESEARCH 24

3.4 BREAKDOWN OF PRIMARY RESPONDENTS 25

3.5 FORECASTING TECHNIQUES 26

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 27

3.6.1 BOTTOM-UP APPROACH 28

3.6.2 TOP-DOWN APPROACH 28

3.7 DATA TRIANGULATION 29

3.8 VALIDATION 29

4 MARKET DYNAMICS 30

4.1 OVERVIEW 30

4.2 DRIVERS 31

4.2.1 SHIFT TOWARDS HOMECARE SETTINGS IS BOOSTING THE DEMAND FOR PORTABLE DEVICES 31

4.2.2 INCREASING TECHNOLOGICAL ADVANCEMENT 31

4.2.3 RISING PREVALENCE OF CHRONIC DISEASES BOOSTS THE DEMAND FOR MEDICAL DEVICES 31

4.3 RESTRAINTS 32

4.3.1 HIGH COST OF MEDICAL DEVICES 32

4.3.2 THREAT TO DATA SECURITY &STRICT REGULATORY COMPLIANCE 32

4.4 OPPORTUNITIES 33

4.4.1 INCREASING RESEARCH & DEVELOPMENT INVESTMENT 33

5 MARKET FACTOR ANALYSIS 34

5.1 VALUE CHAIN ANALYSIS 34

5.1.1 R&D AND DESIGNING 35

5.1.2 MANUFACTURING 35

5.1.3 DISTRIBUTION & SALES 35

5.1.4 POST-SALES SERVICES 35

5.2 PORTER’S FIVE FORCES MODEL 36

5.2.1 THREAT OF NEW ENTRANTS 36

5.2.2 BARGAINING POWER OF SUPPLIERS 36

5.2.3 THREAT OF SUBSTITUTES 37

5.2.4 BARGAINING POWER OF BUYERS 37

5.2.5 INTENSITY OF RIVALRY 37

5.3 IMPACT OF COVID-19 ON THE MEDICAL DEVICE MARKET 37

5.3.1 IMPACT ON THE SUPPLY CHAIN 37

5.3.2 IMPACT ON PRODUCTION 37

5.3.3 IMPACT ON REGIONS 38

5.3.4 DEMAND-SUPPLY GAP ANALYSIS 38

5.3.5 IMPACT ON PRICING 38

5.4 ROBOTICS USED IN HEALTHCARE MANUFACTURING PROCESSES 38

6 GLOBAL MEDICAL DEVICES MARKET, BY DEVICE TYPE 39

6.1 OVERVIEW 39

6.2 DRUG DELIVERY SYSTEMS 40

6.2.1 METERED DOSE INHALER DEVICES 41

6.2.2 INFUSION SYSTEMS 43

6.2.3 OTHERS 43

6.3 DIAGNOSTIC DEVICES 43

6.3.1 LABORATORY BASED DIAGNOSTIC DEVICES 45

6.3.1.1 X-RAY 46

6.3.1.2 COMPUTED TOMOGRAPHY (CT) 46

6.3.1.3 POSITRON EMISSION TOMOGRAPHY (PET) 46

6.3.1.4 OTHERS 47

6.3.2 WEARABLE DIAGNOSTIC DEVICES 47

6.3.2.1 VITAL SIGNS MONITORS 48

6.3.2.2 FETAL AND OBSTETRIC MONITORING DEVICES 48

6.3.2.3 OTHERS 48

6.3.3 OTHERS 49

6.4 INVASIVE DEVICES 49

6.4.1 IMPLANTS AND STIMULATION DEVICES 50

6.4.2 DEFIBRILLATORS 52

6.4.3 PACEMAKERS 52

6.4.4 OTHERS 52

6.5 RESPIRATORY THERAPEUTIC DEVICES 53

6.5.1 VENTILATORS 54

6.5.2 OXYGEN CONCENTRATORS 54

6.5.3 RESUSCITATORS 55

6.5.4 OTHERS 55

6.6 ELECTRONIC MEDICAL DEVICE 55

6.6.1 MONITORING DEVICES 57

6.6.1.1 SPHYGMOMANOMETER 58

6.6.1.2 PULSE OXIMETER 58

6.6.1.3 DIGITAL THERMOMETERS 58

6.6.1.4 BRAIN WAVE METE 59

6.6.1.5 ELECTROCARDIOGRAM METER 59

6.6.1.6 BODY FAT METER 59

6.6.1.7 BONE DENSITY METER 60

6.6.1.8 PHYSIOLOGICAL MONITORING SYSTEM 60

6.6.1.9 OTHERS 60

6.6.2 MASSAGE CHAIRS 61

6.6.3 HEATING BLANKETS 61

6.6.4 ELECTRONICAL HOSPITAL BEDS 61

6.6.5 OTHERS 62

6.7 OTHERS 62

7 GLOBAL MEDICAL DEVICES MARKET, BY APPLICATION 63

7.1 OVERVIEW 63

7.2 CARDIOVASCULAR DISEASES 65

7.3 DIAGNOSTIC IMAGING 65

7.4 ORTHOPEDICS 66

7.5 ONCOLOGY 66

7.6 OPHTHALMOLOGY 67

7.7 GENERAL SURGERY 67

7.8 RESPIRATORY 68

7.9 DENTAL 68

7.10 ENT 69

7.11 NEUROLOGY 69

7.12 NEPHROLOGY & UROLOGY 70

7.13 OTHERS 70

8 GLOBAL MEDICAL DEVICES MARKET, BY END USER 71

8.1 OVERVIEW 71

8.2 HOSPITALS & CLINICS 72

8.3 AMBULATORY SURGICAL CENTERS 73

8.4 HOMECARE SETTINGS 73

8.5 OTHERS 74

9 GLOBAL MEDICAL DEVICES MARKET, BY REGION 75

9.1 OVERVIEW 75

9.2 NORTH AMERICA 77

9.2.1 US 82

9.2.2 CANADA 87

9.3 EUROPE 92

9.3.1 GERMANY 99

9.3.2 UK 104

9.3.3 FRANCE 108

9.3.4 ITALY 112

9.3.5 SPAIN 116

9.3.6 REST OF EUROPE 121

9.4 ASIA-PACIFIC 126

9.4.1 JAPAN 133

9.4.2 CHINA 138

9.4.3 INDIA 143

9.4.4 AUSTRALIA 148

9.4.5 SOUTH KOREA 154

9.4.6 REST OF ASIA-PACIFIC 160

9.5 REST OF THE WORLD 167

9.5.1 MIDDLE EAST 173

9.5.2 AFRICA 179

9.5.3 LATIN AMERICA 184

10 COMPETITIVE LANDSCAPE 190

10.1 OVERVIEW…………………………………………………………………………………………………………………………………………………………………………………….191

10.2 COMPETITIVE BENCHMARKING 192

10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL EPILEPSY DEVICES MARKET 193

10.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL MEDICAL DEVICES MARKET 194

10.5 KEY DEVELOPMENTS & GROWTH STRATEGIES 195

10.5.1 PRODUCT LAUNCH 195

10.5.2 COLLABORATION 195

10.5.3 AGREEMENT 195

10.5.4 ACQUISITION 195

10.5.5 PARTNERSHIP 195

10.6 MAJOR PLAYERS FINANCIAL MATRIX 195

10.6.1 SALES (USD MILLION), 2021 195

10.6.2 R&D (USD MILLION), 2021 196

11 COMPANY PROFILE 197

11.1 ABBOTT 197

11.1.1 COMPANY OVERVIEW 197

11.1.2 FINANCIAL OVERVIEW 198

11.1.3 PRODUCTS OFFERED 199

11.1.4 KEY DEVELOPMENTS 199

11.1.5 SWOT ANALYSIS 200

11.1.6 KEY STRATEGIES 200

11.2 FRESENIUS SE & CO. KGAA 201

11.2.1 COMPANY OVERVIEW 201

11.2.2 FINANCIAL OVERVIEW 201

11.2.3 PRODUCTS OFFERED 202

11.2.4 KEY DEVELOPMENTS 202

11.2.5 SWOT ANALYSIS 203

11.2.6 KEY STRATEGIES 203

11.3 GE HEALTHCARE 204

11.3.1 COMPANY OVERVIEW 204

11.3.2 FINANCIAL OVERVIEW 204

11.3.3 PRODUCTS OFFERED 205

11.3.4 KEY DEVELOPMENTS 209

11.3.5 SWOT ANALYSIS 209

11.3.6 KEY STRATEGIES 209

11.4 JOHNSON & JOHNSON SERVICES INC. 210

11.4.1 COMPANY OVERVIEW 210

11.4.2 FINANCIAL OVERVIEW 210

11.4.3 PRODUCTS OFFERED 211

11.4.4 KEY DEVELOPMENTS 211

11.4.5 SWOT ANALYSIS 212

11.4.6 KEY STRATEGIES 212

11.5 MEDTRONIC 213

11.5.1 COMPANY OVERVIEW 213

11.5.2 FINANCIAL OVERVIEW 213

11.5.3 PRODUCTS OFFERED 214

11.5.4 KEY DEVELOPMENTS 215

11.5.5 SWOT ANALYSIS 215

11.5.6 KEY STRATEGIES 216

11.6 SIEMENS 217

11.6.1 COMPANY OVERVIEW 217

11.6.2 FINANCIAL OVERVIEW 217

11.6.3 PRODUCTS OFFERED 218

11.6.4 KEY DEVELOPMENTS 220

11.6.5 KEY STRATEGIES 220

11.7 STRYKER 221

11.7.1 COMPANY OVERVIEW 221

11.7.2 FINANCIAL OVERVIEW 221

11.7.3 PRODUCTS OFFERED 222

11.7.4 KEY DEVELOPMENTS 222

11.7.5 KEY STRATEGIES 222

11.8 BOSTON SCIENTIFIC CORPORATION 223

11.8.1 COMPANY OVERVIEW 223

11.8.2 FINANCIAL OVERVIEW 223

11.8.3 PRODUCTS OFFERED 224

11.8.4 KEY DEVELOPMENTS 225

11.8.5 KEY STRATEGIES 225

11.9 BECTON, DICKINSON AND COMPANY 226

11.9.1 COMPANY OVERVIEW 226

11.9.2 FINANCIAL OVERVIEW 227

11.9.3 PRODUCTS OFFERED 228

11.9.4 KEY DEVELOPMENTS 228

11.9.5 KEY STRATEGIES 228

11.10 BIO-RAD LABORATORIES, INC. 229

11.10.1 COMPANY OVERVIEW 229

11.10.2 FINANCIAL OVERVIEW 229

11.10.3 PRODUCTS OFFERED 230

11.10.4 KEY DEVELOPMENTS 230

11.10.5 KEY STRATEGIES 230

12 APPENDIX 231

12.1 REFERENCES 231

12.2 RELATED REPORTS 232